July 2, 2003

MEDIA CONTACTS: Amy Heaps or Pierre Gantt
(410) 955-1287
heapsam@jhmi.edu or ganttpi@jhmi.edu

DeWeese First Director of Hopkins' New Radiation Oncology Department

Theodore L. DeWeese, M.D., has been named the first director of the new Department of Radiation Oncology at Johns Hopkins Medicine. Director of Hopkins' Radiation Biology program since 2000, he was selected after an extensive national search to lead the newly designated department, which provides a wide spectrum of radiation treatment to cancer patients. The appointment was made by Edward D. Miller, M.D., Dean and CEO of Johns Hopkins Medicine, and by Ronald R. Peterson, President of The Johns Hopkins Health System and Hospital.

Recognized as a leader in the study of urologic malignancies, DeWeese is internationally known for his translation of gene therapy concepts from the laboratory to the bedside. He and his collaborators were the first to use a prostate-specific adenovirus for the treatment of prostate cancer in humans. For the National Cancer Institute of the National Institutes of Health, he leads a Specialized Program of Research Excellence (SPORE) translational science grant project and is principal investigator of a Program Project Grant on the mechanisms of cellular radiation response. He also leads a Department of Defense Cancer Consortium grant project in adenoviral gene therapy. His research encompasses laboratory and clinical studies of mechanisms to enhance radiation sensitization of prostate cancer.

In his new position, DeWeese will be responsible for building the new department, which is an integrated entity of the Johns Hopkins Kimmel Cancer Center, including recruiting new faculty, overseeing the radiological basic science program and clinical operations.

"Ted has a wonderful ability to inspire and mentor others. His colleagues at Johns Hopkins and elsewhere describe him as ‘a program builder and a visionary,' who is skilled at bringing together multidisciplinary teams of clinical and laboratory investigators. Indeed, he is the ideal person to lead our radiation oncology program as it takes on increasing importance in the fight against cancer," says Miller.

DeWeese has been at Johns Hopkins since 1991, when he arrived for his residency in radiation oncology, and joined the faculty in both Oncology and Urology in 1995. He received his medical degree with honors in 1990 from the University of Colorado School of Medicine in Denver and completed an internship in internal medicine at Franklin Square Hospital in Baltimore before coming to Johns Hopkins for his residency. He also completed a post-doctoral research fellowship in urologic oncology at Hopkins. He is the author of more than 75 articles, abstracts and book chapters.


Related Web Sites:
www.hopkinsmedicine.org
www.hopkinskimmelcancercenter.org

 


 


-- JHMI --
Search Press Releases

-----------------------------------------
News Media Home | Hopkins Medicine Home